TGFβ-regulated transcriptional mechanisms in cancer

International Journal of Gastrointestinal Cancer

Volumn 31, Issue 1-3, 2002, Pages 61-69

  Ellenrieder, Volker ^a   Buck, Anita ^a   Gress, Thomas M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Epithelial mesenchymal transdifferentiation; Smad; TGF ; TIEG

Indexed keywords

GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P300; RAS PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; GENE CONTROL; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; CELL DIFFERENTIATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; NEOPLASM; PATHOPHYSIOLOGY;

CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036934416     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Massague J, Chen YG. Controlling TGFβ signaling. Genes Dev 2000;14:627-644.
2. Blobe GC, Schiemann WP, Lodish HF. Role of TGFβ in human disease. N Eng J Med 2000;342:1350-1358.
3. de Caestecker MP, Piek E, Roberts AB. The role of TGFβ signaling in cancer. J Natl Cancer Inst 2000;92:1388-1402.
4. Itoh S, Itoh F, Goumans MJ, et al. Signaling of TGFβ family members through Smad proteins. Eur J Biochem 2000;267:6954-6967.
5. Reiss M. TGFβ and cancer. Microbes Infect 1999;1:1327-1347.
6. Akhurst RJ, Balmain A. Genetic events and the role of TGFβ in epithelial tumour progression. J Pathol 1999;187:82-90.
7. Portella G, Cumming SA, Liddell J, et al. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 1998;9:393-404.
8. Chen RH, Ebner R, Derynck R. Inactivation of the type-II receptor reveals two receptor pathways for the diverse TGFβ activities. Science 1993;260:1335-1338.
9. Akhurst RJ, Derynck R. TGFβ signaling in cancer - a double-edged sword. Trends Cell Biol 2001;11:44-51.
10. Cui W, Fowlis D, Bryson S, et al. TGFβ1 inhibits the formation of benign skin tumours but enhances progression to invasive spindle cell carcinomas in transgenic mice. Cell 1996;86:531-542.
11. Welch DR, Fabra A, Nakajima M, et al. TGFβ stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 1990;87:7678-7682.
12. Ellenrieder V, Hendler SF, Ruhland C, et al. TGFβ induced invasiveness of pancreatic cancer cells is mediated by MMP-2 and the urokinase plasminogen activator system. Int J Cancer 2001;93:204-211.
13. Massague J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
14. Zhao J, Buick RN. Regulation of transforming growth factor beta receptors in H-ras oncogene transformed rat intestinal epithelial cells. Cancer Res 1995;55:6181-6188.
15. Ellenrieder V, Hendler SF, Boeck W. TGFβ1 treatment leads to an epithelial-mesenchymal-transdifferentiation of pancreatic cancer cells requiring ERK2 activation. Cancer Res 2001;61:4222-4228.
16. Massague J, Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J 19:1745-1754.
17. Heldin CH, Miyazono K, ten Djike P. TGFβ signaling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-471.
18. Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGFβ-inducible antagonist of TGFβ signaling. Nature 1997;389:631-635.
19. Imamura T, Takase M, Nishihara A, et al. Smad6 inhibits signaling by the TGFβ superfamily. Nature 1997;389:622-626.
20. He W, Cao T, Smith DA, et al. Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. Oncogene 2001;20:471-483.
21. Kleeff J, Ishiwata T, Maruyama H, et al. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 1999;18:5363-5372.
22. Wrana JL. Crossing Smads. Sci STKE 2000;23:RE1.
23. Zhang Y, Derynck R. Regulation of Smad signaling by protein associations and signaling crosstalk. Trends Cell Biol 1999;9:274-279.
24. Piek E, Roberts AB. Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. Adv Cancer Res 2001;83:1-54.
25. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000;1:169-178.
26. Ellis CA, Clark G. The importance of being K-Ras. Cell Signal 2000;12:425-434.
27. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532.
28. Kretzschmar M, Doody J, Timokhina I, et al. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev 1999;13:804-816.
29. Mulder KM: Role of Ras and MAPKs in TGFβ signaling. Cytokine Growth Factor Rev 2000;11:23-35.
30. Frey RS, Mulder KM. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 1997;57:628-633.
31. Calonge MJ, Massague J. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells. J Biol Chem 1999;274:33,637-33,643.
32. +)-calmodulin-dependent protein kinase II. Mol Cell Biol 2000;20:8103-8111.
33. Yakymovych I, ten Dijke P, Heldin CH, et al. Regulation of Smad signaling by protein kinase C. FASEB J 2001;15:553-555.
34. Engel ME, McDonnell MA, Law BK, et al. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 1999;274:37,413-37,420.
35. Brown JD, DiChiara MR, Anderson KR, et al. MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem 1999;274:8797-8805.
36. Frey RS, Mulder KM. TGFβ regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Lett 1997;117:41-50.
37. Shibuya H, Yamaguchi, Shirakabe K, et al. Identification of a member of the MAPKKK family as a potential mediator of TGFβ signal transduction. Science 1995;270:2008-2011.
38. Atfi A, Djelloul S, Chastre E, et al. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem 1997;272:1429-1432.
39. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor beta induced gene expression. J Biol Chem 1999;274:27,161-27,167.
40. Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998;394:909-913.
41. Moustakas A, Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 1998;95:6733-6738.
42. Chen X, Rubock MJ, Whitman M. A transcriptional partner for MAD proteins in TGFbeta signaling. Nature 1996;383:691-696.
43. Yanagisawa J, Yanagi Y, Masuhiro Y, et al. Convergence of transforming growth factor beta and vitamin D signaling pathways on Smad transcriptional coactivators. Science 1999;283:1317-1321.
44. Feng XH, Zhang Y, Wu RY, et al. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGFβ-induced transcriptional activation. Genes Dev 1998;12:2153-2163.
45. Janknecht R, Wells NJ, Hunter T. TGFβ-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev 1998;12:2114-2119.
46. Wotton D, Lo RS, Lee S, et al. A Smad transcriptional corepressor. Cell 1999;97:29-39.
47. Stroschein SL, Wang W, Zhou S, et al. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 1999;286:771-774.
48. Izutsu K, Kurokawa M, Imai Y, et al. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood 2001;97:2815-2822.
49. Recio JA, Merlino G. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 2002;21:1000-1008.
50. van Dam H, Castellazzi M. Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene 2001;20:2453-2464.
51. Luo K, Stroschein SL, Wang W, et al. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev 1999;13:2196-2206.
52. Goggins M, Shekher M, Turnacioglu K, et al. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 1998;58:5329-5332.
53. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-353.
54. Schutte M, Hruban RH, Hedrick L, et al. DPC4 in various tumor types. Cancer Res 1996;56:2527-2530.
55. Eppert K, Scherer SW, Ozcelik H, et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinomas. Cell 1996;86:543-552.
56. Donovan J, Slingerland J. Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res 2000;2:116-124.
57. Seoane J, Pouponnot C, Staller P, et al. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 2001;3:400-408.
58. Amati B. Integrating Myc and TGF-beta signalling in cell-cycle control. Nat Cell Biol 2001;3:112-113.
59. Chen CR, Kang Y, Massague J. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc Natl Acad Sci USA 2001;98:992-999.
60. Cook T, Urrutia R. TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth. Am J Physiol Gastrointest Liver Physiol 2000;278:513-521.
61. Tachibana I, Imoto M, Adjei PN, et al. Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 1997;99:2365-2374.
62. Cook T, Gebelein B, Mesa K, et al. Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger encoding genes involved in the regulation of cell growth. J Biol Chem 1998;273:25,929-25,936.
63. Ellenrieder V, Fernandez-Zapico M, Urrutia R. TGFβ-mediated signaling and transcriptional regulation in pancreatic development and cancer. Curr Opin Gastroenterol 2001;17:434-440.
64. Zhang JS, Moncrieffe MC, Kaczynski J, et al. A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol Cell Biol 2001;21:5041-5049.
65. Ellenrieder V, Zhang JS, Kaczynski J, et al. Signaling disrupts mSin3A binding to the Mad1-like Sin3 interacting domain of TIEG2, an Sp1-like repressor. EMBO J 2002;21:2451-2460.
66. Ellenrieder V, Adler G, Gress TM. Invasion and metastasis in pancreatic cancer. Ann Oncol 1999;4:46-50.
67. Oft M, Heider KH, Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998;8:1243-1252.
68. Oft M, Peli J, Rudaz C, et al. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996;10:2462-2477.
69. Miettinen PJ, Ebner R, Lopez AR, et al. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994;127:2021-2036.
70. Malats N, Porta M, Corominas JM, et al. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int J Cancer 1997;17:661-667.
71. Lemoine NR, Jain S, Hughes CM, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992;102:230-236.
72. Wagner M, Kleeff J, Friess H, et al. Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer. Pancreas 1999;19:370-376.
73. Friess H, Yamanaka Y, Buchler M, et al. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-1856.
74. Geng MM, Ellenrieder V, Wallrapp C, et al. Use of representational difference analysis to study the effect of TGFβ on the expression profile of a pancreatic cancer cell line. Genes Chromosomes Cancer 1999;26:70-79.
75. Janda E, Lehmann K, Killisch I, et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002;156:299-313.
76. Lehmann K, Janda E, Pierreux CE, et al. Raf induces TGF-beta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 2000;14:2610-2622.